Skip to main content
. Author manuscript; available in PMC: 2016 Dec 14.
Published in final edited form as: Peptides. 2014 Jun 14;59:20–24. doi: 10.1016/j.peptides.2014.06.004

Fig. 1.

Fig. 1

Plasma glucose levels (top panel) in five dogs receiving GLP-1(32–36)amide (■) or saline (○) vehicle and glucose infusion rates (lower panel, thick line = GLP infusion). The vertical line at 60 and 180 min indicate the interval of GLP-1(32–36)amide or saline infusions.